The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis (Q38239170)

31 August 2017

title

The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis (English)

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Patrizia Ripa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Antonio Carolei

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

13 August 2014

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1043-1055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

Migraine prevalence, disease burden, and the need for preventive therapy

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine: the seventh disabler

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Progression of cardiovascular damage: the role of renin-angiotensin system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Rationale for double renin-angiotensin-aldosterone system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The CNS renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The role of angiotensin II in cognition and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The angiotensin II type 2 receptor in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Neural plasticity and the brain renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Brain renin-angiotensin—A new look at an old system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The role of the central renin-angiotensin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Prevention of migraine with olmesartan in patients with hypertension/prehypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Enkephalinase Inhibition Relieves Pain Syndromes of Central Dysnociception (Migraine and Related Headache)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Peripheral vascular dysfunction in migraine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Nuclear factor-kappaB as a molecular target for migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Mast cell involvement in the pathophysiology of migraine headache: A hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Mast cells and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine pain, meningeal inflammation, and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

CGRP and NO in the trigeminal system: mechanisms and role in headache generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Intraneuronal angiotensinergic system in rat and human dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Participation of nucleus reticularis gigantocellularis in the antinociceptive effect of angiotensin III in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Altered PPARgamma expression and activation after transient focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Meta-analysis of the ACE gene in ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine and genetic polymorphisms: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin I-converting enzyme gene (I/D) polymorphism in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Combined effects of ACE and MMP-3 polymorphisms on migraine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

ACE D/I polymorphism, migraine, and cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Association between ACE inhibitors use and headache caused by nitrates among hypertensive patients: results from the Italian group of pharmacoepidemiology in the elderly (GIFA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine and cardiovascular disease in women and the role of aspirin: Subgroup analyses in the Women’s Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Comorbid neuropathologies in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine and vascular diseases: a review of the evidence and potential implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Migraine and hemorrhagic stroke: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Vascular smooth muscle cell dysfunction in patients with migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Mast cells: pivotal players in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2014.946408

10.1586/14737175.2014.946408

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25115162%20AND%20SRC:MED&resulttype=core&format=json